The 20 Best Renal Oncocytoma Doctors Near Me in Bronx, NY

Ian Ganly is a General Surgeon practicing medicine in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy. Dr. Ganly is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Richard V. Smith, MD, FACS, is Chair, Otorhinolaryngology-Head & Neck Surgery, Professor, Otorhinolaryngology-Head & Neck Surgery, Professor, Surgery and Professor, Pathology at Montefiore Einstein. Dr. Smith’s clinical focus is on head and neck surgery, including transoral robotic and laser surgery for throat and larynx cancer, salivary gland, thyroid and parathyroid surgery. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Parathyroidectomy.

Jonathan Smith is an Otolaryngologist practicing medicine in Bronx, New York. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Nonallergic Rhinopathy, Palatal Myoclonus, Ozena, and Jones Syndrome.

Bradley A. Schiff, MD, is Professor, Otorhinolaryngology- Head & Neck Surgery, Director, Otorhinolaryngology- Head & Neck Surgery and Director, Head & Neck Cancer Service at Montefiore Einstein. His clinical focus is on all aspects of head and neck cancer surgery including cancers and masses of the oral cavity, larynx, pharynx and neck as well as tumors of the parotid thyroid and parathyroid glands. Dr. Schiff is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Gastrostomy, and Laryngectomy.

Vikas Mehta, MD, MPH, FACS, is the Vice Chair and an Associate Professor in the Department of Otorhinolaryngology-Head & Neck Surgery at Montefiore Einstein. His clinical focus is on the treatment of patients with head and neck cancer, diseases of the salivary glands and thyroid/parathyroid disease, with a particular interest in transoral robotic surgery and minimally invasive endocrine surgery. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Oral Squamous Cell Carcinoma, Gastrostomy, and Laryngectomy.

Michael Lipsky is a Urologist practicing medicine in New York, New York. Dr. Lipsky is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His clinical expertise encompasses Prostate Cancer, Urinary Tract Infection (UTI), UPJ Obstruction, Ureteroscopy, and Cystectomy.

Stephen W. Reese, MD, is an attending physician at Montefiore Einstein and Assistant Professor at our Albert Einstein College of Medicine. Dr. Reese cares for patients with urologic cancers, using minimally invasive and open surgical approaches. He has a particular interest in the management of urologic cancers, including kidney, prostate, bladder, adrenal and testicular cancer and works to care for patients in a multidisciplinary setting with his colleagues in medical and radiation oncology. In 2017, Dr. Reese received his Doctor of Medicine at Boston University School of Medicine. He completed his residency training at Brigham and Women’s Hospital in Boston, MA in 2022 and then completed a Society of Urologic Oncology (SUO) Fellowship at Memorial Sloan Kettering Cancer Center in 2024. Dr. Reese is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Venous Thromboembolism (VTE), Prostate Cancer, Nephrectomy, and Cystectomy.

Marc Janis is a Urologist practicing medicine in Mount Vernon, New York. Dr. Janis is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

"Brett Miles, DDS, MD, is vice president of otolaryngology for Northwell facilities in New York City boroughs and Westchester County. He is also the chair of otolaryngology and head and neck surgery at Lenox Hill Hospital and Manhattan Ear, Eye Throat Hospital, and the surgical lead of the head and neck disease management team in the Northwell Health Cancer Institute.Dr. Miles manages head and neck tumors, including those of the mouth and throat, with state-of-the-art surgical techniques including microvascular reconstruction. His clinical interests include computerized reconstruction, minimally invasive robotic surgery and HPV-related head and neck cancer.""Head and neck cancer can be challenging to treat, but highly meaningful,"" Dr. Miles says. ""The relationships I form with my patients are a source of personal motivation. Seeing them move forward with their lives after treatment is inspiring.""Dr. Miles earned a medical degree from University of Texas Southwestern Medical School and a doctorate of dental surgery from Creighton University. He completed residencies in Oral and Maxillofacial surgery and Otolaryngology-Head and Neck surgery at the University of Texas Southwestern Medical Center. He received fellowship training in head and neck oncology at the University of Toronto and is board-certified by both the American Board of Oral and Maxillofacial Surgery and the American Board of Otolaryngology - Head Neck Surgery.Dr. Miles works collaboratively with a team of experts to offer the highest quality cancer care and access to clinical trials. They include imaging specialists, radiation oncologists, medical oncologists, nurse practitioners, and speech and swallowing therapists.Dr. Miles is a Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He has published 170 articles in peer-reviewed journals and often lectures at national and international conferences. He is on the council of the International Association of Oral Oncology, and the American Head and Neck Society's Reconstructive Head and Neck Research Board. He has been a New York Magazine and a New York Metro Area Top Doctor for the last several years.Overall, compassion and empathy are integral to his job. ""Undergoing cancer surgery is a very stressful time for patients and families,"" Dr. Miles says. ""My focus is on cancer and the people affected by cancer.""". Dr. Miles is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Human Papillomavirus Infection, Adenoid Cystic Carcinoma, Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Miles is board certified in American Board Of Oral & Maxillofacial Surgery and American Board Of Otolaryngology-Head & Neck Surgery.

I strive to provide the best and most current techniques in head and neck surgery. Following my training at the University of Toronto, Cedars Sinai in Los Angeles and Sloan Kettering here in NY, I was appointed as Residency Director at Manhattan Eye Ear Throat Hospital. Since 1987, I have been in private practice in Manhattan and Queens, where I am the Chief of the Head and Neck Service. I have had over 30 years of experience dealing with tumors in this region.My interests include thyroid and parathyroid surgery, salivary gland surgery, cancers of the oral cavity and larynx and the treatment of sinusitis. Nerve monitoring during complex surgery is frequently utilized.This is a solo practice so all patients are seen and treated by myself, both in the office and in the operating room. Dr. Shemen is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Nonsyndromic Hearing Loss, Deafness Hypogonadism Syndrome, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Swallowing Difficulty, and Thyroidectomy. Dr. Shemen is board certified in American Board Of Otolaryngology.

Philip Perlman is an Otolaryngologist practicing medicine in Manhasset, New York. Dr. Perlman is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Palatal Myoclonus, Nonallergic Rhinopathy, Ozena, and Infant Hearing Loss.

Sanford Dubner is an Otolaryngologist practicing medicine in Lake Success, New York. Dr. Dubner is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Hyperparathyroidism, Thyroidectomy, and Thymectomy. Dr. Dubner is board certified in American Board Of Plastic Surgery.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Vishal Gupta is a General Surgeon practicing medicine in Bronx, New York. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Laryngectomy.

Salvatore Caruana is an Oncologist practicing medicine in New York, New York. Dr. Caruana is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Male Pattern Baldness, Laryngectomy, and Gastrostomy. Dr. Caruana is currently accepting new patients.

Scott H. Troob M.D is a double-boarded Head and Neck Oncologist & Microvascular and Facial Plastic Surgeon nationally recognized for providing integrated oncologic and reconstructive care. He currently serves as the Division Chief of Facial Plastic and Reconstructive Surgery in the Department of Otolaryngology – Head and Neck Surgery. During his time at Columbia, he developed the Head and Neck Free Tissue Transfer and Facial Reanimation programs and has earned a reputation for technical excellence and compassionate patient care. He specializes in the treatment of benign conditions of the head and neck as well as the medical and surgical treatment of cancers of the skin, oral cavity, oropharynx, larynx, hypopharynx, sinonasal tract, salivary glands, and skull base. Additionally, Dr. Troob employs state-of-the-art tissue repair and microsurgical techniques to perform reconstructive surgery for patients following head and neck cancer treatment, facial trauma, and facial paralysis.Dr. Troob is a proud graduate of Columbia (CC ’04) where he received his undergraduate BA in Biology and served as the Captain of the Men’s Swimming and Diving Team. He then attended Jefferson Medical College where he graduated summa cum laude and was inducted into the Alpha Omega Alpha Honor Medical Society. He went on to complete his Otolaryngology – Head and Neck Surgery Residency in 2014 at NYU, where he was selected for the Gold Humanism Society in recognition of his excellence in humanistic patient care, leadership, compassion, and dedication to service. Following residency, he left New York for Oregon Health and Science University (OHSU), where he completed a fellowship in Advanced Head and Neck Oncology, Robotic, & Skull Base Surgery in 2015. He remained at OHSU to complete a second fellowship in Microvascular and Facial Plastic Surgery in 2016.Beyond his interest in oncology and reconstruction, Dr. Troob treats a variety of disorders of the salivary glands, focusing on minimally invasive procedures (sialoendoscopy) which allow for treatment of strictures and stones without external incisions. Dr. Troob is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Recurrent Peripheral Facial Palsy, Facial Paralysis, Gastrostomy, and Thyroidectomy. Dr. Troob is board certified in Otolaryngology. Dr. Troob is currently accepting new patients.

Guarionex Decastro is a Urologist practicing medicine in New York, New York. Dr. Decastro is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

Andrew T. Lenis, MD MS, is an Assistant Professor of Urology at CUIMC. He specializes in treating patients with bladder, kidney, prostate, testis, and penile cancers. Dr. Lenis graduated from Case Western Reserve University School of Medicine in Cleveland, Ohio, with a dual MD MS degree and Honors Distinction in Research. He then completed his surgical internship and urology residency at UCLA in Los Angeles, California. After residency, Dr. Lenis completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York City.Dr. Lenis joined CUIMC as a surgeon-scientist with an interest and specialization in urothelial cancer (tumors of the bladder, ureter, and renal pelvis). In the laboratory, Dr. Lenis works and collaborates with Michael Shen, Ph.D., who is an expert in bladder and prostate developmental and molecular biology and a pioneer in bladder tumor organoids. The American Urological Association, the American Cancer Society, and the American Society for Clinical Oncology have funded Dr. Lenis’ research. His work on urologic malignancies has been published in JAMA, the Journal of Urology, European Urology, the Journal of Clinical Oncology Precision Oncology, and Urologic Oncology. When not seeing patients or in the laboratory, Dr. Lenis enjoys spending time with his wife and two sons. They enjoy the outdoors and traveling. Dr. Lenis is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy. Dr. Lenis is currently accepting new patients.